Back

Medscape, LLC

  • Cell Transplantation
  • Complement System Proteins

From Bench to Bedside: Prioritizing Early Detection and Complement-Based Interventions in HCT-TMA

The goal of this activity is for learners to be better able to recognize early signs of hematopoietic cell transplantation-associated thrombotic microangiopathy (HCT-TMA) and to apply appropriate screening and treatment strategies.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.5 credits

MOC types

ABIM — Medical KnowledgeUp to 0.5 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.5 credits
  • MOC · Up to 0.5 points
  • Commercial Support
  • Released
    Jan 12, 2026
  • Last day to claim credit
    Jan 13, 2027 3 months left